Skip to main content
Signal8

INTEGRATED BIOPHARMA INC (INBP)

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

Integrated BioPharma, Inc. logo

Integrated BioPharma, Inc.

OTC:INBPConsumer Defensive
-2.94%$0.1650
Mkt Cap$5.12M
Float30.41M
O/S31.06M
Vol
$ Vol
RVOL
Inst Own0.1%
SI<0.1%
Earnings
Dilution
Pipeline3 lead-sponsored trials·0 active3 completed(21 more as collaborator)

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Phase
  • Phase 4
    Completed

    Improving the Management of Acute Coronary Syndromes in the Emergency Department

    Point of Care testing

    Acute Coronary Syndrome

    Enrollment
    705
    Start
    Jun 2011
    Primary Completion
    Dec 2011
    Completion
    Dec 2011
    NCT01563250
  • Observational
    Completed

    Identification of a Plasma Proteomic Signature for Lung Cancer

    -

    Precancerous Conditions, Carcinoma

    Enrollment
    475
    Start
    Oct 2012
    Primary Completion
    Dec 2014
    Completion
    Dec 2014
    NCT01752101
  • Observational
    Completed

    Early Diagnosis of Pulmonary Nodules

    -

    Precancerous Conditions, Carcinoma

    Enrollment
    684
    Start
    Oct 2012
    Primary Completion
    Dec 2016
    Completion
    Dec 2016
    NCT01752114